iCAD (ICAD) Revenue & Revenue Breakdown
iCAD Revenue Highlights
Latest Revenue (Y)
$17.32M
Latest Revenue (Q)
$4.95M
Main Segment (Y)
Product
Main Geography (Y)
Non-US
iCAD Revenue by Period
iCAD Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $17.32M | -38.03% |
2022-12-31 | $27.94M | -16.93% |
2021-12-31 | $33.64M | 13.27% |
2020-12-31 | $29.70M | -5.24% |
2019-12-31 | $31.34M | 22.32% |
2018-12-31 | $25.62M | -8.83% |
2017-12-31 | $28.10M | 6.70% |
2016-12-31 | $26.34M | -36.62% |
2015-12-31 | $41.55M | -5.40% |
2014-12-31 | $43.92M | 32.83% |
2013-12-31 | $33.07M | 16.95% |
2012-12-31 | $28.27M | -1.32% |
2011-12-31 | $28.65M | 16.59% |
2010-12-31 | $24.58M | -12.57% |
2009-12-31 | $28.11M | -25.03% |
2008-12-31 | $37.49M | 40.88% |
2007-12-31 | $26.61M | 34.94% |
2006-12-31 | $19.72M | -0.25% |
2005-12-31 | $19.77M | -15.18% |
2004-12-31 | $23.31M | 257.47% |
2003-12-31 | $6.52M | 30.40% |
2002-12-31 | $5.00M | 3.41% |
2001-12-31 | $4.84M | -37.96% |
2000-12-31 | $7.79M | 16.32% |
1999-12-31 | $6.70M | 26.42% |
1998-12-31 | $5.30M | -32.91% |
1997-12-31 | $7.90M | -30.09% |
1996-12-31 | $11.30M | -45.15% |
1995-12-31 | $20.60M | -15.57% |
1994-12-31 | $24.40M | 18.45% |
1993-12-31 | $20.60M | - |
iCAD generated $17.32M in revenue during NA 2023, up -38.03% compared to the previous quarter, and up 67.59% compared to the same period a year ago.
iCAD Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $4.95M | 4.49% |
2023-12-31 | $4.74M | 16.40% |
2023-09-30 | $4.07M | -30.55% |
2023-06-30 | $5.87M | 1.51% |
2023-03-31 | $5.78M | -10.96% |
2022-12-31 | $6.49M | 2.09% |
2022-09-30 | $6.36M | -16.09% |
2022-06-30 | $7.58M | 0.69% |
2022-03-31 | $7.52M | -3.65% |
2021-12-31 | $7.81M | -16.59% |
2021-09-30 | $9.36M | 19.61% |
2021-06-30 | $7.83M | -9.46% |
2021-03-31 | $8.64M | -17.29% |
2020-12-31 | $10.45M | 46.60% |
2020-09-30 | $7.13M | 28.06% |
2020-06-30 | $5.57M | -15.02% |
2020-03-31 | $6.55M | -30.17% |
2019-12-31 | $9.38M | 19.40% |
2019-09-30 | $7.86M | 7.20% |
2019-06-30 | $7.33M | 8.21% |
2019-03-31 | $6.77M | -2.60% |
2018-12-31 | $6.95M | 12.31% |
2018-09-30 | $6.19M | 0.49% |
2018-06-30 | $6.16M | -2.39% |
2018-03-31 | $6.31M | -20.11% |
2017-12-31 | $7.90M | 12.89% |
2017-09-30 | $7.00M | 9.22% |
2017-06-30 | $6.41M | -5.63% |
2017-03-31 | $6.79M | -1.98% |
2016-12-31 | $6.93M | 15.41% |
2016-09-30 | $6.00M | -18.54% |
2016-06-30 | $7.37M | 22.04% |
2016-03-31 | $6.04M | -20.65% |
2015-12-31 | $7.61M | -20.59% |
2015-09-30 | $9.58M | -14.01% |
2015-06-30 | $11.14M | -15.71% |
2015-03-31 | $13.22M | 0.42% |
2014-12-31 | $13.16M | 4.72% |
2014-09-30 | $12.57M | 30.05% |
2014-06-30 | $9.67M | 13.46% |
2014-03-31 | $8.52M | -6.73% |
2013-12-31 | $9.13M | 10.19% |
2013-09-30 | $8.29M | 7.49% |
2013-06-30 | $7.71M | -2.75% |
2013-03-31 | $7.93M | 1.43% |
2012-12-31 | $7.82M | -4.46% |
2012-09-30 | $8.18M | 37.97% |
2012-06-30 | $5.93M | -6.50% |
2012-03-31 | $6.34M | -4.04% |
2011-12-31 | $6.61M | -17.91% |
2011-09-30 | $8.05M | 21.16% |
2011-06-30 | $6.65M | -9.50% |
2011-03-31 | $7.34M | 15.27% |
2010-12-31 | $6.37M | 14.04% |
2010-09-30 | $5.59M | -8.38% |
2010-06-30 | $6.10M | -6.49% |
2010-03-31 | $6.52M | -19.58% |
2009-12-31 | $8.11M | 14.10% |
2009-09-30 | $7.11M | 24.02% |
2009-06-30 | $5.73M | -20.03% |
2009-03-31 | $7.16M | -23.09% |
2008-12-31 | $9.32M | -16.77% |
2008-09-30 | $11.19M | 6.11% |
2008-06-30 | $10.55M | 64.02% |
2008-03-31 | $6.43M | -20.60% |
2007-12-31 | $8.10M | - |
iCAD generated $4.95M in revenue during Q1 2024, up 4.49% compared to the previous quarter, and up 76.34% compared to the same period a year ago.
iCAD Revenue Breakdown
iCAD Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Product | $9.93M | $15.40M | - | - | - |
Service | $7.39M | - | - | - | - |
Detection | - | - | $22.02M | $22.00M | $22.32M |
Therapy | - | - | $11.62M | $7.70M | $9.02M |
iCAD's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (57.34%), and Service (42.66%).
Quarterly Revenue by Product
Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $3.25M | $3.10M | $2.34M | $2.20M | $2.64M | $2.74M | $3.16M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Service Contracts | $1.77M | $1.85M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Therapy | - | - | - | - | - | - | - | $2.00M | $2.29M | $2.00M | $2.30M | $3.35M | $3.04M | $2.92M | $2.34M | $1.84M | $1.45M | $2.08M | $2.53M | $1.77M |
Detection | - | - | - | - | - | - | - | $4.36M | $5.29M | $5.52M | $5.50M | $6.01M | $4.79M | $5.72M | $8.11M | $5.29M | $4.12M | $4.48M | $6.86M | $6.09M |
iCAD's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (64.70%), and Service Contracts (35.30%).
iCAD Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
---|---|---|---|---|
Non-US | $7.50M | $6.10M | $3.80M | $3.20M |
iCAD's latest annual revenue breakdown by geography, as of Dec 21: Non-US (100.00%).
iCAD Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
NVRO | Nevro | $425.17M | $101.90M |
FNA | Paragon 28 | $216.39M | $61.02M |
ESTA | Establishment Labs | $165.15M | $44.12M |
AXGN | AxoGen | $159.01M | $47.91M |
SIBN | SI-BONE | $138.89M | $39.97M |
SRDX | Surmodics | $132.58M | $30.34M |
SIEN | Sientra | $90.55M | $19.54M |
SRGA | Surgalign | $81.98M | $16.75M |
SGHT | Sight Sciences | $81.06M | $21.37M |
AZYO | Elutia | $49.19M | $6.13M |
LNSR | LENSAR | $42.16M | $10.59M |
CVRX | CVRx | $39.30M | $11.81M |
SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
ICAD | iCAD | $17.32M | $4.95M |
PROF | Profound Medical | $7.33M | $1.90M |
INVO | INVO Bioscience | $3.02M | $1.58M |
AIMD | Ainos | $122.11K | - |
NVNO | enVVeno Medical | - | - |
MOVE | Movano | - | - |
BMRA | Biomerica | - | $1.02M |
ICAD Revenue FAQ
What is iCAD’s yearly revenue?
iCAD's yearly revenue for 2023 was $17.32M, representing a decrease of -38.03% compared to 2022. The company's yearly revenue for 2022 was $27.94M, representing a decrease of -16.93% compared to 2021. ICAD's yearly revenue for 2021 was $33.64M, representing an increase of 13.27% compared to 2020.
What is iCAD’s quarterly revenue?
iCAD's quarterly revenue for Q1 2024 was $4.95M, a 4.49% increase from the previous quarter (Q4 2023), and a -14.26% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $4.74M, a 16.40% increase from the previous quarter (Q3 2023), and a -26.94% decrease year-over-year (Q4 2022). ICAD's quarterly revenue for Q3 2023 was $4.07M, a -30.55% decrease from the previous quarter (Q2 2023), and a -35.92% decrease year-over-year (Q3 2022).
What is iCAD’s revenue growth rate?
iCAD's revenue growth rate for the last 3 years (2021-2023) was -48.52%, and for the last 5 years (2019-2023) was -44.74%.
What are iCAD’s revenue streams?
iCAD's revenue streams in c 23 are Product, and Service. Product generated $9.93M in revenue, accounting 57.34% of the company's total revenue, down -35.51% year-over-year. Service generated $7.39M in revenue, accounting 42.66% of the company's total revenue
What is iCAD’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of iCAD was Product. This segment made a revenue of $9.93M, representing 57.34% of the company's total revenue.